La obesidad como problema médico
1St Bartholomew's & The Royal London School of Medicine, Queen Mary & Westfield College, UK. P.G.Kopelman@mds.qmw.ac.uk
Nature
|April 15, 2000
Resumen
La obesidad es una creciente crisis de salud mundial, superando a la desnutrición y las infecciones como una de las principales causas de enfermedad. Está vinculada a enfermedades graves como la diabetes, las enfermedades cardíacas y el cáncer, que requieren atención urgente.
Área de la Ciencia:
- Salud Pública La salud pública.
- Epidemiología La epidemiología.
- Trastornos metabólicos Los trastornos metabólicos son trastornos metabólicos que se producen en el cuerpo.
Sus antecedentes:
- La obesidad es un problema de salud global significativo, cada vez más frecuente en todo el mundo.
- Se asocia con afecciones graves de salud, incluida la diabetes mellitus, la enfermedad coronaria, los cánceres y los trastornos respiratorios del sueño.
- Las definiciones tradicionales que utilizan el índice de masa corporal (IMC) no capturan completamente los riesgos para la salud, particularmente los relacionados con la grasa intraabdominal.
Objetivo del estudio:
- Para resaltar la creciente epidemia mundial de obesidad.
- Subrayar las múltiples consecuencias para la salud de la obesidad más allá de las preocupaciones cosméticas.
- Hacer hincapié en la necesidad de abordar la obesidad como una gran amenaza para la salud pública.
Principales métodos:
- Revisión de los datos epidemiológicos actuales sobre la prevalencia de la obesidad.
- Análisis de las asociaciones establecidas entre la obesidad y las principales enfermedades no transmisibles.
- Discusión de los factores etiológicos que contribuyen a la epidemia de obesidad.
Principales resultados:
- La obesidad está emergiendo como una de las principales causas de morbilidad y mortalidad a nivel mundial.
- Existe una fuerte correlación entre la obesidad y el desarrollo de enfermedades crónicas.
- Factores como la predisposición genética, el mayor acceso a alimentos con alto contenido calórico y la reducción de la actividad física impulsan la epidemia.
Conclusiones:
- La obesidad es una epidemia compleja con profundas implicaciones para la salud mundial.
- Requiere un cambio de perspectiva de un problema cosmético individual a un desafío generalizado de salud pública.
- Abordar las causas profundas de la obesidad es fundamental para mejorar el bienestar mundial.
Videos de Conceptos Relacionados
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients
372
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330
Bulimia Nervosa
1.1K
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K
Binge Eating Disorders
832
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
832


